Pharma’s Almanac 9/15/23 Read the full article >> Sonja Wustrack, Managing Director of Integrated Evidence Generation, OM1 There are two points to this question around RWD and RWE today. The first piece is the misconception that we primarily need larger volumes of higher quality RWD and better data standards to shift the paradigm for clinical research to incorporate RWE[…]
Pharma’s Almanac 9/15/23 Read the full article >> Sonja Wustrack, Managing Director of Integrated Evidence Generation, OM1 OM1 is a real-world data (RWD) and health technology company focused on ingestion, normalization, and linkage of multiple sources of RWD, including structured and unstructured data. The integration of these various sources (EHR, claims, and patient-generated data, for example) provides a more[…]
MAPS Webinar 9/15/23 Listen to the full webianr >> Clinical research is typically costly for sponsors and burdensome for providers and patients. New methods and approaches, such as integrated evidence generation using real-world data networks and automated study platforms, are accelerating the path from start-up to read out.
Listen to the full podcast >> Healtheconmoncs.com July 26, 2023 On this episode of tHEORetically speaking features Gary Curhan, Chief Medical Officer and Jessica Paulus, Vice President of Research at OM1, as they answer questions on Leveraging Real-World Data for Precision Obesity Treatment.
Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1, the leading real-world data and technology company focused on chronic conditions, today announced the launch of its Parkinson’s Disease (PD) premium dataset and the enhancement of its Mental Health & Neuroscience Real-World Data Network. The dataset includes more than 7,000 patients prospectively followed by neurologists in hundreds of clinics across[…]
